GSK seeks bids for $4bn India sale by mid-Sept
UK pharmaceutical giant GSK has requested bids by mid-September for its $4.3-billion Indian consumer-health unit, which owns the popular malted milk brand Horlicks, people with knowledge of the matter said.…
Today non-pharma companies are also filing for drug approvals : Kunwar B Kishore Arora
Shahid Akhter, editor, ETHealthworld spoke to Kunwar B Kishore Arora, Global CEO and COO, APCER Life Sciences, New Delhi. to know more about the trends and developments in pharmacovigilance industry.…
FDA declines to approve Allergan’s Esmya
Allergan Plc said on Tuesday U.S. health regulators had declined to approve Esmya, its treatment for abnormal uterine bleeding in women with uterine fibroids, requesting more information and citing safety…
Torrent Pharma recalls 14 lots of blood pressure drug from US
New Delhi: Drug firm Torrent Pharmaceuticals is recalling 14 lots of tablets used for treatment of high blood pressure and heart failure from the US market due to presence of…
Price of J&J’s TB drug to drop by more than half
In what will come as good news for tuberculosis (TB) patients, life-saving drug bedaquiline by US pharma company Johnson & Johnson (J&J) is now being offered at $400 per patient…
Jubilant Life Sciences plans Rs 550-cr capex in FY19
MUMBAI: Pharma company Jubilant Life Sciences has earmarked Rs 550 crore for capital expenditure (capex) in the current financial year, a top company official said. It is also planning to…
Illegal internet drugs pharmacy busted in Delhi, 4 held
New Delhi: An illegal internet pharmacy, allegedly shipping drugs to overseas locations like the US and Canada, based in Delhi has been busted by the NCB with the apprehension of…
Serum Institute to launch dengue vaccine in South America next year
The country’s largest vaccine manufacturer, Serum Institute of India, will be launching its dengue vaccine in South America next year, as the company prepares to file for regulatory approvals in…
AstraZeneca Pharma India gets DCGI nod to market cancer drug in India
New Delhi: Drug firm AstraZeneca Pharma India today said it has received permission from the Drug Controller General of India (DCGI) to import and market olaparib tablets used for the…
Nationwide alert in China for the faulty rabies vaccine
The second largest drug manufacturing company “ Changchun Changsheng Life Sciences” were found guilty for violated national standards including usage of expired fluids and falsified production dates to produce rabies…
